Zealand presents at three investor conferences in March

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Zealand presents at three investor conferences in March 2015

Copenhagen, 2015-02-26 11:48 CET (GLOBE NEWSWIRE) -- Copenhagen, 26 February 2015 – Zealand Pharma A/S (“Zealand”) (Nasdaq Copenhagen: ZEAL) today informs that in March 2015 the company will present at the three investor conferences listed below, taking place in London, Paris and Copenhagen, respectively.

At the conferences, representatives from Zealand’s management team will meet with and present to investors, providing an update on the company’s most recent achievements, including the Lyxumia® royalty bond financing of USD 50 million, on the status for the portfolio of both proprietary and partnered medicines in development, as well as on the catalyst outlook for 2015.

Credit Suisse One-on-One Healthcare Conference, London (3-4 March)

Tuesday 3 March: Zealand hosting one-to-one and small group meetings.

Zealand representatives: President and CEO Britt Meelby Jensen and Vice President, Head of IR and Corporate Communications Hanne Leth Hillman

Exane BNP Paribas Healthcare Conference, Paris (17-18 March)

Tuesday 17 March: Zealand group presentation at 16:30 CET and hosting of one-to-one meetings.

Zealand representatives: President and CEO Britt Meelby Jensen and Vice President, Head of IR and Corporate Communications Hanne Leth Hillman

InvestorDagen, Copenhagen (18 March) – Danish Shareholders Association

Wednesday 18 March from 11:30am-7:30pm CET: Zealand group presentation and exhibition at the event.

Please note that no new financial or other material new information relating to Zealand will be disclosed at the above listed conferences.

●●●●●

For further information, please contact:

Hanne Leth Hillman, Vice President, Head of Investor Relations & Corporate Communications

Tel: +45 50 60 36 89, email: hlh@zealandpharma.com

About Zealand Pharma

Zealand Pharma A/S (“Zealand”) (Nasdaq Copenhagen: ZEAL) is a biotechnology company based in Copenhagen, Denmark. Zealand has leading expertise in the discovery, design and development of novel peptide medicines and possesses in-house competences in clinical trial design and management with a therapeutic focus on metabolic diseases and acute care indications. The company is advancing a proprietary pipeline of novel medicines alongside a partnered product and development portfolio.

Zealand’s first invented medicine, lixisenatide, a once-daily prandial GLP-1 agonist for the treatment of Type 2 diabetes, is marketed globally (ex-US) as Lyxumia® and in Phase III development as a single-injection combination with Lantus® (LixiLan), both under a global license agreement with Sanofi. US regulatory filing for Lyxumia® is planned for Q3 2015 and US/EU filings for LixiLan in Q4 2015.

Zealand proprietary pipeline includes danegaptide (prevention of Ischemic Reperfusion Injury) and the stable glucagon product, ZP4207 (treatment of severe hypoglycemia) as well as several preclinical peptide therapeutics. Partnering represents an important component of strategy to leverage in-house expertise, share development risk in large clinical trials, provide funding and commercialize the company’s products. Zealand currently has global license agreements and partnerships with Sanofi, Helsinn Healthcare, Boehringer Ingelheim and Eli Lilly.

For further information: www.zealandpharma.com         Follow us on Twitter @ZealandPharma

Scroll down for more posts ▼

Top 10 Most Recent News Articles

7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 235

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 89

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 192

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 262

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 427

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 516

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 337

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 451

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 337

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Market for Pressure Ulcer Care Solutions in Japan

Updated Category News Views 184

Growth of the Pressure Ulcer Care Dressing Market in Japan The Japan pressure ulcer care dressing market is expected to surge significantly, with forecasts predicting a market valuation exceeding US$ 226.75 million by 2032. This marks a substantial increase from the US$ 129.68 million recorded in 2023, reflecting a compound annual growth rate (CAGR) of 6.52% during the...

Continue Reading
Harnessing Innovation: RS Transforms Discrete Manufacturing

Updated Category News Views 135

Harnessing Innovation in Discrete Manufacturing Whether your business is at the beginning stages of digital transformation or is already scaling, RS is equipped with the products and expertise necessary to implement smart solutions tailored to your operational needs. RS, a leading global provider of high-service product and service solutions for industrial clients, is...

Continue Reading
Dr. Lu Xianping's Impact on China's Pharmaceutical Innovation

Updated Category News Views 121

Dr. Lu Xianping Receives Prestigious Entrepreneur Award Recently, Dr. Lu Xianping, the Founder and Chairman of Shenzhen Chipscreen Biosciences Co., Ltd, received accolades as the Chinese mainland winner of a prominent entrepreneur award. This recognition is a testament to his commitment to enhancing quality and innovation in the pharmaceutical field. Significance of the...

Continue Reading
Saturna Capital Unveils Enhanced HSA for Muslim Investors

Updated Category News Views 204

Updates to the Shifa Health Savings Account Saturna Capital Corporation has recently enhanced its Shifa Health Savings Account (HSA), tailoring it specifically for the unique needs of Muslim investors. This innovative HSA incorporates Islamic Investment Principles, ensuring it aligns with religious beliefs while meeting the highest standards in the industry. Features of...

Continue Reading
Understanding Cipher Mining's Short Interest and Market Trends

Updated Category News Views 240

What’s Happening with Cipher Mining’s Stock? Cipher Mining's short percentage of float has recently recorded an increase of 19.77%. The company now reports a total of 53.60 million shares that have been sold short, representing a significant 20.48% of all shares available for trading. Based on current trading volumes, traders would require approximately 1.32 days to...

Continue Reading